According to Biodesix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.6798. At the end of 2023 the company had a P/S ratio of 3.39.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.39 | -26.34% |
2022 | 4.60 | 75.53% |
2021 | 2.62 | -77.67% |
2020 | 11.7 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
LabCorp LH | 1.44 | -60.78% | ๐บ๐ธ USA |
OpGen
OPGN | 1.89 | -48.60% | ๐บ๐ธ USA |
NeoGenomics
NEO | 3.10 | -15.89% | ๐บ๐ธ USA |